Hologic (HOLX) Stock Price & AI Analysis

$58.02
-$0.27
(0.46%)
Health Care Equipment

NASDAQ USA

April 27, 3:32 PM EDT
  • Market Cap.
    13.02B
  • Volume
    1.81M
  • Avg. Volume
    2.78M
  • Target Price
    $76.27
  • 52W Range
    55.89 - 84.67
  • RSI (14)
    42.67
  • Beta
    0.55
  • PEG Ratio
    2.38
  • SMA 20
    -1.83%
  • SMA 50
    -5.40%
  • SMA 200
    -21.11%
  • Insider Owner
    0.86%
  • Insider Trans
    -1.27%
  • Institution Owner
    103.35%
  • Institution Trans
    -0.18%
  • Short Interest
    6.53%
  • EPS next Y
    8.71

Hologic Company Profile

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Hologic | Latest news

Hologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside?

According to Roots Analysis, the IVD market is projected to witness a 6.2% compound annual growth...

Zacks - 6 days ago

Hologic (HOLX) Stock Moves -1.08%: What You Should Know

Hologic (HOLX) closed the most recent trading day at $56.94, moving -1.08% from the previous trading...

Zacks - 6 days ago

Hologic Set to Report Q2 Earnings: Buy, Sell or Hold the Stock?

Free Report) is set to release second-quarter fiscal 2025 results on May 1, after the closing bell....

Zacks - 3 days ago

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...

Zacks - 4 days ago

Hologic, Inc. (NASDAQ:HOLX) Given Average Recommendation of “Hold” by Analysts

Shares of Hologic, Inc. (NASDAQ:HOLX – Get Free Report) have earned a consensus rating of “Hold” from the seventeen ratings firms that are presently covering the company, Marketbeat Ratings ...

ETF DAILY NEWS - 2 days ago

...Environmental, Social and Governance Efforts -- Including Expanded...

\n Hologic, Inc. (HOLX) commits to reducing emissions by 50% by 2030 and achieving net zero by 2050. The company's technologies impacted over 193 million l

Guru Focus - 5 days ago

3 Cash-Producing Stocks Walking a Fine Line

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with...

StockStory - 5 days ago

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be...

\n Hologic's (HOLX) AI-Powered Mammography Technology findings to be showcased at SBI Symposium. Massachusetts General Hospital study analyzed 5,000 radiol

Guru Focus - 3 days ago

Hologic Inc (HOLX) Releases 2024 Sustainability Report Highlighting...

Hologic Inc (HOLX, Financial), a leader in women's health technology, has published its annual sustainability report, emphasizing its expanded environmental commitments and efforts to enhance ...

Guru Focus - 5 days ago